Sarepta Therapeutics Inc.

(SRPT) Trade

By |

Profile

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Contact Information

Website: www.sarepta.com
Email: investors@sarepta.com
Main Phone: +1 617 274-4000
Address: 215 First Street
Address 2: Suite 415
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Douglas S. Ingram
Employees: 255
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 121.67 $ -0.35 (-0.29%)
Last Price 121.67 Change $ -0.35 Change % -0.29 Tick N/A
Bid 121.53 Bid Size 100.00 Ask 121.80 Ask Size 100.00
Open 120.57 High 123.50 Low 119.66 Prev Close 122.02
Last Trade Volume 275,078 52 Wk Hi 176.50 52 Wk Low 50.68
Market Cap 8.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 66,823,624.00 EPS (TTM) -3.76 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 76
Number of Buys 4 43
Number of Sells 4 33
Net Activity 14946 491537
Last 10 Buys Shares
Douglas S. Ingram 1,000
Douglas S. Ingram 1,000
M. Kathleen Behrens 1,000
M. Kathleen Behrens 1,000
Richard J. Barry 1,000
Gil Price 1,000
Christopher Garabedian 1,000
Edward M. Kaye 1,000
Anthony R. Chase 1,000
M. Kathleen Behrens 1,000
Last 10 Sell Shares
Hans Wigzell 1,000
Shamim Ruff 1,000
Shamim Ruff 1,000
Shamim Ruff 1,000
Shamim Ruff 1,000
Sandesh Mahatme 1,000
Sandesh Mahatme 1,000
David T. Howton 1,000
David T. Howton 1,000
Sandesh Mahatme 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 121 121 121 121
Low Target Price Estimate 64 64 64 64
Mean Target Price Estimate 96.83 95.75 95.75 96.83
Standard Deviation 14.56 14.38 14.38 14.56
Date of Most Recent Estimate 06/01/18 05/14/18 05/14/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 11 11 11 11
Moderate Buy 2 2 2 3
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.3